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Table 2 HR of all-cause mortality according to levels of eGFR in different kinds of treatment cancer patients.
Baseline levels of eGFR (ml/min/1.73m2)
90 60-89 <60
HR (95%Cl) p-value HR (95%Cl) p-value HR (95%Cl) p-value
Best supportive care cancer patients
Unadjusted Ref. 1.073 (0.852-1.352) 0.548 2.203 (1.482-3.275) <0.001
Adjusted
Model 1 Ref. 0.753 (0.582-0.976) 0.032 1.448 (0.940-2.228) 0.093
Model 2 Ref. 0.848 (0.644-1.117) 0.241 1.567 (0.983-2.499) 0.059
Model 3 Ref. 1.125 (0.831-1.523) 0.445 1.637 (1.022-2.621) 0.040
Single treatment cancer patients
Chemotherapy
Unadjusted Ref. 1.260 (1.098-1.446) 0.001 2.546 (1.812-3.578) <0.001
Adjusted
Model 1 Ref. 0.985 (0.849-1.143) 0.843 1.619 (1.137-2.305) 0.008
Model 2 Ref. 1.022 (0.876-1.193) 0.779 1.586 (1.095-2.296) 0.015
Model 3 Ref. 1.117 (0.944-1.323) 0.198 1.671 (1.112-2.511) 0.014
Surgery
Unadjusted Ref. 1.181 (1.024-1.363) 0.023 1.350 (0.975-1.870) 0.071
Adjusted
Model 1 Ref. 0.961 (0.820-1.127) 0.625 1.056 (0.749-1.490) 0.755
Model 2 Ref. 1.010 (0.858-1.190) 0.901 1.068 (0.743-1.536) 0.721
Model 3 Ref. 1.078 (0.912-1.274) 0.377 0.967 (0.673-1.391) 0.858
Combined treatment cancer patients
Unadjusted Ref. 1.529 (1.264-1.849) <0.001 2.831 (1.781-4.500) <0.001
Adjusted
Model 1 Ref. 1.037 (0.845-1.272) 0.728 1.693 (1.050-2.729) 0.031
Model 2 Ref. 1.056 (0.859-1.298) 0.604 1.753 (1.083-2.836) 0.022
Model 3 Ref. 1.036 (0.837-1.283) 0.742 1.320 (0.763-2.283) 0.321
Model 1: Adjusted for age, sex.
Model 2: Model 1+ BMI, HP, CVD, DM, smoking, drinking.
Model 3: Model 2 + ALB, ALT, AST, TG, GLU, hemoglobin, CRP.
Chronic Kidney Disease S111all-cause mortality (HR Z 1.272; 95% CI, 1.031e1.570; p Z 0.025). On sub-
group analysis, for patients received surgery, combination treatment,
eGFR < 60 ml/min/1.73 m2 was not an independent risk factor for all-cause
mortality, however, it was an independent risk factor for patients who
received chemotherapy (HR Z 1.671; 95% CI, 1.112e2.511; p Z 0.014) or
BSC (HR Z 1.637; 95% CI, 1.022e2.621; p Z 0.040).
Conclusion: RI appears frequently for patients with newly diagnosed solid
cancer. eGFR < 60 ml/min/1.73 m2 is an independent risk factor for all-
cause mortality, but for patients who received different treatments, its in-
fluence on death works differently.http://dx.doi.org/10.1016/j.hkjn.2015.09.158
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Relationship Between Vascular Calcification and Oxidative Stress in the
Early Stage of Chronic Kidney Disease
L. Zheng
Xiangya Hospital, Central South University, Changsha, China
Objective: Established the animal model of early stage of CKD and
detection whether the vascular calcification is happened. Then
investigated the relationship between vascular calcification and oxidative
stress.
Methods: 6 male 10 weeks SD rats fed with chow containing 0.75% adenine,
0.25% protein, 1.06% calcium and 0.92% phosphorus. Collect the 24-hour
urine and serum in weeks 0, 2, 3 and 4 to measure creatinine clearance
rate. 32 male 11 weeks SD rat, collect the 24-hour urine and randomly
divided into normal group, contrast feeding group, model group and treat-
ment group. The latter two groups were fed with chow above-mentioned.
Give the MnTMPyP 30 nmol per day intraperitoneally to treatment group.
The other two groups were fed with standardized chow containing the
same calcium and phosphorus. Make the intake of contrast feeding group
same with model group. After 4 weeks, anesthetize the rats collect blood
and 24-hour urine to measure serum biochemical parameters and 8-OHdG
in ELISA. Collect aortas to measure Von Kossa staining and calcium content
assay. Runx2, SM22a were measured in western blot.Results: The kidney of model group and treatment group appeared as “big
white kidney”. The cortex tend to thin and the demarcation of medulla is
unclear. The glomerulus atrophy and a lot of black crystal deposited on
the renal interstitium and lymphocyte infiltrated in the interstitium. Also
the creatinine increased and creatinine clearance decreased significantly
(p < 0.01). And accord with the standard of early CKD in rats. And the hypo-
calcemia and hyperphosphatemia are significantly too (p < 0.01). 8-OHdG,
calcium content and calcification increased significantly and treatment
group has a downward trend. The expression of SM22a significant descreased
while Runx2 is increased.
Conclusion: CKD-MBD have already occurred in early stage of CKD. Phosphorus
and oxidative stress participated in the vascular calcification and the phenotype
transdifferentiation of VSMCs is the principal reason in it.http://dx.doi.org/10.1016/j.hkjn.2015.09.159
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Waist-to-hip Ratio is Associated with Chronic Kidney Disease
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Objective: To evaluate the association between the anthropometric indices
of obesity and CKD and investigate the predictive value of waist-to-hip
circumference on CKD.
Methods: A total of 346 participants were enrolled in this study from January
2012 to August 2014 in General Hospital of Ningxia Medical University,
including 167 patients with CKD and 179 patients of healthy people as the
control group. Indices of obesity included body mass index, waist circumfer-
ence and waist-to-hip ratio (WHR). A multivariate logistic regression model
was used to analyze the associations between CKD and its risk factors with
the anthropometric indices of obesity. Receiver operating characteristic
(ROC) curves make further to explore the predictive value of various indices
of obesity on CKD.
Results: (1) The mean age of CKD patients (99 male and 68 female) was
38.0  8.7 years while the mean age of healthy control group (92 male
and 87 female) was 36.3  8.5 years. (2) The significant higher level of
S112 Chronic Kidney DiseaseSBP, DBP, BMI, WC, WHR, TG, TC, LDL, BUN, Scr, UA and FBG were seen in
CKD patients compared with the healthy control group, while the lower level
of hemoglobin, albumin and HDL were shown in the CKD group. (3) Multivar-
iate logistic regression model analysis showed WHR was positively correlated
with CKD (OR Z 9.470; 95% CI, 3.146e28.511; P < 0.001). (4) Compared to
the other indices of obesity, ROC curve analysis showed WHR was the best
diagnostic indicator in predicting CKD. The AUC of WHR, WC and BMI were
0.847 (95% CI, 0.804e0.890), 0.840 (95% CI, 0.799e0.882) and 0.755 (95%
CI, 0.703e0.807), respectively. A cut-off value of 0.87 of WHR had a sensi-
tivity of 76.6% and a specificity of 82.1%.
Conclusion: In the indices of obesity, WHR was an optimal predictor in pre-
dicting CKD. In addition, it is easy to use.http://dx.doi.org/10.1016/j.hkjn.2015.09.160
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Objective: The growing burden of end-stage renal disease (ESRD) has been a
great challenge to the health care system of China. However, the exact
epidemiological data for ESRD in China remain unclear. We aimed to deter-
mine the real burden of ESRD in China through analyzing ten-year data of
Nanjing three million insurance covered population.
Methods: Using the electronic registry system of Urban Employee Basic Med-
ical Insurance (UEBMI), we included all subjects insured by UEBMI in Nanjing
from 2005 to 2014, and we identified subjects who developed ESRD in this
cohort. The prevalence, incidence, mortality rate and long-term survival
rate of ESRD were analysed based on this unique data system.
Results: The UEBMI population in Nanjing increased from 1,301,882 in 2005
to 2,921,065 in 2014, among which a total of 5840 subjects developed ESRD
and received RRT. Over the 10-year period, the annual incidence rates of
ESRD in the UEBMI cohort in Nanjing gradually decreased from 289.3 pmp
in 2005 to 218.8 pmp in 2014. However, the prevalence rate increased
steadily from 891.7 pmp in 2005 to 1228.6 pmp in 2014. The annual mortality
rate decreased from 138.4 per 1000 patient-years in 2005 to 97.8 per 1000
patient-years in 2014. The long-term survival rate of ESRD fluctuated over
the past decade, with the 1-year survival rate ranging from 85.1% to
91.7%, the 3-year survival rate from 69.9% to 78.3% and the 5-year survival
rate from 58% to 65.4%.
Conclusion: China is confronted with enormous burden of ESRD and will
possess the largest population requiring RRT in the world with medical re-
form. Medical communities and the government should undertake active
measures to control this coming crisis.http://dx.doi.org/10.1016/j.hkjn.2015.09.161
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Objective: To evaluate the impact of improvement of cardiac function after
cardiac valve surgery to the renal outcome in preoperative renal dysfunction
patients.
Methods: Data from patients who had preexisting renal dysfunction [serum
creatinine (SCr)> 1.2 mg/dl, or eGFR 60 mL/min/1.73 m2) and received car-
diac valve surgery from April 2009 to May 2011 were analyzed.6LVEFZ postoperative LVEF e preoperative LVEF. Patients were grouped ac-
cording to thepostoperative cardiac function changeas following: Cardiac func-
tion not improved (CFNI group)Z 6EF  0%; Cardiac function improved (CFI
group) Z 6EF > 0%. Cardiac function significantly improved (CFSI
group) Z 6EF  15%. Cardiac function partial improved (CFPI
group)Z 0% <6EF < 15%.
Results: A total of 164 patients were enrolled. Pre- and postoperative LVEF
were 58  11% and 59  11%. Pre- and postoperative SCr were 1.7  0.8 and
1.6  1.1 mg/dl. The postoperative incidence of AKI was 44% (nZ 72), inci-
dence of AKI requiring replacement therapy (AKI-RRT) was 9% (nZ 14). The
AKI incidence in CFI group was significantly lower than in CFNI group (35% vs.
57%, PZ 0.009). There was no statistical significance of AKI eRRT incidence
and postoperative SCr between the two groups (5% vs. 13%, P Z 0.087;
1.5  0.8 vs. 1.8  1.5 mg/dL, P Z 0.135). The AKI incidence in CFSI group
and CFPI group were both significantly lower than in CFNI group (34% vs. 57%,
P < 0.05; 36% vs. 57%, P < 0.05). The postoperative SCr in CFSI group was
lower than preoperative SCr in the same group (1.2  0.3 vs.
1.4  0.2.mg/dL, P Z 0.027). Multivariate logistic regression analysis
showed that improved cardiac function after surgery (OR Z 0.42; 95% CI,
0.2e0.86) can reduce the risk of AKI while age (OR Z 1.06; 95% CI,
1.02e1.09) was independent risk factor of AKI.
Conclusion: For patients with preoperative renal dysfunction and cardiac
function improved after surgery, the AKI incidence would significantly lower
than those whose cardiac function not improved and postoperative renal
function is probably better than renal function before surgery.http://dx.doi.org/10.1016/j.hkjn.2015.09.162
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Objective: Sagliker Syndrome (SS), with craniofacial deformation, is a rare
disease derived from uremic secondary hyperparathyroidism (SHPT). This
study aims to investigate the clinical features of SS in Chinese patients.
Methods: We retrospectively assessed 9 SS patients underwent total para-
thyroidectomy (TPTX) with autotransplantation (AT). The other 137 common
SHPT patients with the same treatment were observed as the control group.
Clinical presentations, laboratory tests and follow-up data were recorded.
The follow-up status was considered as “effectiveness” if serum intact para-
thyroid hormone (iPTH) levels were <150 pg/mL in the first 3 days after sur-
gery, or as “recurrence” if serum iPTH gradually increased >300 pg/mL
during follow-up in patients whose status was initially considered as
“effectiveness”.
Results: Craniofacial deformations (9/9 vs. 0/137, SS vs. control, the same
below), short stature (9/9 vs. 16/137), thoracocyllosis (9/9 vs. 38/137)
and spine malformations (9/9 vs. 29/137) were observed in SS patients
significantly more frequently than in the control group (P < 0.05). The level
of serum iPTH and alkaline phosphatase were significantly elevated in SS pa-
tients than in control. Mean iPTH levels reached up to 3242.5 pg/mL in SS
and 1786.3 pg/mL in control (P < 0.05). After surgery, one SS patient died
from respiratory failure, and no control group patient died. Surgery was
effective in the remaining 10 SS patients with stopped craniofacial deforma-
tion and in 134/137 control group patents (P > 0.05). A mean follow-up of
16.5 (6 to 24) months was available. 6/11 SS patients and 8/137 control
group patients suffered from recurrence of hyperparathyroidism originating
from autografts (P < 0.05).
Conclusion: Our data suggests that SS is not only craniofacial malformations
but is a severe systemic disease. TPTX with AT seems an effective treatment
to relieve SHPT and to improve bone disease. SS, as a severe disease with
high postoperative recurrence tendency, is sufficed to show a disaster in Chi-
nese SHPT patients.http://dx.doi.org/10.1016/j.hkjn.2015.09.163
